Scope and regulation

A worker confirming delivery schedules with a driver at a receiving dock
Confirming delivery schedules with the driver
DemandSourcingProductionStorageDeliveryWholesale

Good Distribution Practice (GDP)

Japan's GDP guidelines set out how to maintain the quality and integrity of medicines as they move from manufacturers through pharmaceutical wholesalers (distributors supplying pharmacies and healthcare providers) to pharmacies and healthcare institutions.

Although they do not have the binding force of legislation, they increasingly serve as practical standards in trading conditions and audits. We begin by mapping gaps in quality management, organization and training, facilities and equipment, deviations, complaints and recalls, self-inspection, and documentation and records.

An aisle of temperature-controlled pharmaceutical storage
An aisle of temperature-controlled storage

Temperature records and excursion decisions

Refrigerated and frozen products require records that allow a third party to verify afterwards that temperatures were maintained.
Deciding every excursion on an ad hoc basis increases both disposal costs and staff workload.

Insulated boxes and temperature loggers
Insulation materials and temperature loggers

Identification codes and traceability

Prescription medicine and medical device packaging requires identification codes including product codes, expiry dates and lot numbers.
Even companies that have completed labeling often have yet to connect those codes to shipping and inventory records.
We test how many days it would take to identify affected products in a recall and reveal where records break down.

Hands scanning an identification code on a medicine box
Scanning packaging identification codes

Distribution and wholesaler transactions

Guidelines for prescription medicine distribution call for product-by-product price negotiations and early price agreements, prompting reviews of trading conditions. We organize the underlying transaction data and analyze the structures that generate returns and disposal, rather than negotiate prices.

A worker sorting returns at a distribution center
Sorting returns

Transport capacity constraints

Working-hour restrictions in Japan's transport sector are affecting pharmaceutical supply planning through fewer delivery services, longer lead times on long-distance routes and less flexibility in delivery times.
We help reposition inventory to reduce delivery frequency without increasing stockouts, and move away from reliance on emergency deliveries.
We also define evaluation criteria for joint delivery arrangements.

Workers loading insulated boxes into a refrigerated truck and checking temperature loggers
Loading refrigerated transport and checking temperatures

API sourcing and supply uncertainty

Some active pharmaceutical ingredients (APIs) used in Japan rely heavily on imports, and concentration in a particular country or factory is repeatedly cited as a trigger for supply interruptions.
For each product, we map supplier countries, manufacturing sites and available alternatives, summarizing concentration and switching time in one table.
We then distinguish products that need more stock from those that need additional sources.

Illustration of a globe connecting many products to one distant factory

Services outside our scope

We do not act as an agent for regulatory applications or notifications, attend conformity inspections, or represent clients in inquiries to authorities. We do not trade medicines or operate logistics services. Where a final legal interpretation is needed, we work with legal counsel and regulatory specialists while focusing on operational design and implementation.

This defined scope protects the independence of our advice.

A consultant reviewing regulatory documents with a specialist
Reviewing documents with a specialist